Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Multiconsult ASA – Calendar effect Q3 2024

Multiconsult ASA (OSE: MULTI)The technical calculation of the calendar effect impacts the Alternative Performance Measure for Q3 2024.Q3 2024:Calendar effect: In the third quarter there was one more working day compared to the third quarter of 2023, due to having two additional days in July and one fewer day in August 2024 compared to 2023. This had an estimated negative impact of NOK 6.1 million on net operating revenues and operating results. YTD 2024:Calendar effect: Year to date of 2024, there were, on average, the same number of working days as in the same period in 2023.

Phase Holographic Imaging PHI AB receives approx. SEK 5.2 million through warrant exercise

On 3 October 2024, the exercise period for warrants of series TO 4, which were issued in connection with Phase Holographic Imaging PHI AB’s ("PHI" or the “Company") rights issue of units in 2022 (“TO 4”), ended. In total, 1,129,513 warrants of series TO 4 were exercised, corresponding to a subscription rate of approximately 83.9 percent. PHI is thus provided approximately SEK 5.2 million before deduction of transaction related costs.Outcome of the exercise of warrants of series TO 4 During the exercise period, 12 september-3 October 2024, holders of TO 4 had the right to subscribe for

Aixia Group AB (publ) terminates the agreement on liquidity guarantee for the share

Mölndal                                                                             2024-10-04 Aixia Group AB (publ) terminates the liquidity guarantee agreement with Pareto Securities. The agreement ends on 9 October 2024. For more info: Mattias Bergkvist, CEOTelephone: 031-762 02 40info@aixia.sewww.aixia.se Aixia Group delivers IT infrastructure, operation and cloud services. Today, the company works with AI and building data centers for development within AI. In addition, the company has its own development of software for ML Ops (machine learning operations) and

Neonode Terminates Agreement with Redeye

STOCKHOLM, SWEDEN, October 4, 2024 — Neonode Inc. (NASDAQ: NEON) (“Neonode” or the “Company”) today announced that the Company has terminated its corporate broking services agreement with Redeye AB (“Redeye”), pursuant to which agreement Redeye provided Neonode with financial advisory and investor relation services.The Company remains committed to enhancing shareholder value and will be exploring alternative options to ensure effective communication with its stakeholders and the broader investment community. For more information, please contact:

#24-99 Information regarding the last day of trading in paid subscribed shares in Rentunder Holding AB

The rights issue in Rentunder Holding AB is now registered with the Swedish Companies Registration Office and the last day of trading in paid subscribed shares has been set for October 7, 2024.   Information regarding the affected instrument:   Listing name: Rentunder Holding BT Exchange symbol: RENT BT ISIN-code: SE0022757852 CFI-code: ESNUFR FISN-code: RENTUNDER/SH Last day of trading: 2024-10-07 Instrument-ID: FHX4 Market-ID: NSME Segment-ID: NSSE   For more information about this Market Notice, please contact us by e-mail, marketsurveillance@ngm.

Invitation to presentation of HEXPOL's Interim Report Q3 on 25 October

HEXPOL will release the Interim Report for the third quarter 2024 on Friday 25 October at about 13:00 CET. The report will be presented by HEXPOL’s President and CEO Klas Dahlberg and deputy CEO and CFO Peter Rosén at a web-casted conference call on 25 October at 14:00 CET. The presentation can be followed on the web or over the phone. If you wish to participate via webcast please use the link below. https://ir.financialhearings.com/hexpol-q3-report-2024 

NoHo Partners Plc: Managers’ Transactions (Virlander)

NoHo Partners Plc, Managers’ Transactions, 4 October 2024 at 16:00 EET NoHo Partners Plc: Managers’ Transactions (Virlander) ____________________________________________ Person subject to the notification requirementName: Henri VirlanderPosition: Other senior manager Issuer: NoHo Partners OyjLEI: 743700DYZ6R1QNLWQA56Notification type: INITIAL NOTIFICATIONReference number: 80395/7/6 ____________________________________________ Transaction date: 2024-10-03Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000064332Nature of transaction:

NoHo Partners Plc: Managers’ Transactions (Koivula)

NoHo Partners Plc, Managers’ Transactions, 4 October 2024 at 16:00 EET NoHo Partners Plc: Managers’ Transactions (Koivula) ____________________________________________ Person subject to the notification requirementName: Maria KoivulaPosition: Other senior manager Issuer: NoHo Partners OyjLEI: 743700DYZ6R1QNLWQA56Notification type: INITIAL NOTIFICATIONReference number: 80398/5/4 ____________________________________________ Transaction date: 2024-10-04Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000064332Nature of transaction: ACQUISITION

NoHo Partners Plc: Managers’ Transactions (Meli)

NoHo Partners Plc, Managers’ Transactions, 4 October 2024 at 16:00 EET NoHo Partners Plc: Managers’ Transactions (Meli) ____________________________________________ Person subject to the notification requirementName: Paul MeliPosition: Other senior manager Issuer: NoHo Partners OyjLEI: 743700DYZ6R1QNLWQA56Notification type: INITIAL NOTIFICATIONReference number: 80394/9/14 ____________________________________________ Transaction date: 2024-10-02Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000064332Nature of transaction: DISPOSAL

NoHo Partners Plc: Managers’ Transactions (Paul Meli Holdings Oy)

NoHo Partners Plc, Managers’ Transactions, 4 October 2024 at 16:00 EET NoHo Partners Plc: Managers’ Transactions (Paul Meli Holdings Oy) ____________________________________________ Person subject to the notification requirementName: Paul Meli Holdings OyPosition: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In IssuerName: Paul MeliPosition: Other senior manager Issuer: NoHo Partners OyjLEI: 743700DYZ6R1QNLWQA56Notification type: INITIAL NOTIFICATIONReference number: 80404/6/6 __________________________________

Katalysen Ventures continues to increase its stake in InvitePeople

Katalysen Ventures AB (publ) (“Katalysen”) is pleased to announce that it has been increasing its stake in Matchmeeting AB (“InvitePeople”). Katalysens total stake in InvitePeople is now approximately 16.9% of which around 14.8% is through shares.Katalysen is expecting both significant short- and long-term results from its investment in InvitePeople, a leader in hybrid event software for enterprises. With over 100 clients, including major brands like IKEA and Deutsche Bahn, and a strong presence in the Swedish and German markets, InvitePeople is well-positioned for growth and the ongoing

Election committee for Vitrolife AB (publ)

The following people have been appointed as members of the election committee for Vitrolife AB for the Annual General Meeting in 2025: Niels Jacobsen, appointed by William Demant Invest A/SPatrik Tigerschiöld, appointed by Bure Equity ABPatricia Hedelius, appointed by AMF Fonder & PensionJón Sigurdsson, Chairman of the Board The appointments have been made in accordance with the instructions regarding principles for the appointment of the company election committee which were determined at the Annual General Meeting of Vitrolife AB on April 25, 2024.The Annual General Meeting

Spermosens recruits first couple for clinical study on next-generation male fertility diagnostic product

Spermosens AB (“Spermosens” or the “Company”) is pleased to announce a significant milestone in its clinical study of the next-generation fertility diagnostic product. The first couple has now been recruited for the study, which is designed to assess the diagnostic value of JUNO-Checked in male infertility. The clinical study, currently underway at the Reproductive Medicine Center (RMC) in Malmö, follows ethical approval for the study. Spermosens’ next-generation device, developed in collaboration with Flex Medical Solutions (FMS), features improved performance and faster read-out times,

Munters announces changes in the Group Executive Management Team

Munters announces today that Stefan Måhl, Group Vice President Business Excellence, has decided to leave the company. Stefan Måhl has held his current position since 2020 and has worked at Munters for nearly 20 years in various leadership positions. He will leave Munters to retire on January 15, 2025."With his industry knowledge, drive, and strong commitment, Stefan has contributed significantly to Munters growth journey and innovative progress. Both I and the colleagues at Munters will miss him as he enters a new phase in life," says Klas Forsström, CEO and Group President of Munters. "

Inside information: Bioretec updates its financial targets

Bioretec Ltd  Company announcement 4 October 2024 at 2:31 p.m. EESTBioretec Ltd announced today, 4 October 2024, that Bioretec's board of directors had decided to update the company's product development strategy by accelerating the product development of the RemeOs™ Spinal Interbody Cage following the granting of Breakthrough Device Designation status by the US Food and Drug Administration on 14 March 2024. Due to the acceleration of the product development of the RemeOs™ Spinal Interbody Cage, Bioretec's Board of Directors has today updated Bioretec's financial targets as follows:

Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage

Bioretec Ltd Company announcement 4 October 2024 at 2:30 p.m. EESTBioretec updates its product development strategy by accelerating the product development of the RemeOs™ Spinal Interbody Cage, an innovative medical device engineered from a multifunctional, MRI-compatible, absorbable hybrid composite based on the company's proprietary magnesium alloy. The decision to accelerate the product development of the RemeOs™ Spinal Interbody Cage is based on an evaluation by the company following the granting of Breakthrough Device designation by the US Food and Drug Administration on March 2024.

Pemamek Iberia celebrates successful Grand Opening of new facilities in Zaragoza

Pemamek, a global leader in welding automation, is proud to announce the successful inauguration of its new facilities in Zaragoza, marking a significant milestone in the company’s ongoing expansion into the Spanish and Portuguese markets. The event, held on October 1, 2024, gathered representatives from the Government of Aragón, the City of Zaragoza, the Ambassador of Finland to Spain, and key industry professionals.[Majority of the event speakers gathered in a group photo From the left Juha Mkitalo CEO Pemamek Oy Roberto Dominguez CEO Arasol Industrial Peter Senz Sales Director Pemamek

Updated time for publication of financial reports and invitation to Q3 presentation

Eastnine has updated the time for publication of upcoming financial reports and report presentation according to the following: · Interim report January–September 2024 will be published on 24 October 2024 at 14.00 CET and report presentation will be held at 15.00 CET on the same day. · Year-end report January–December 2024 will be published on 5 February 2025 at 14.00 CET and report presentation will be held at 15.00 CET on the same day. Presentation of interim report January–September 2024 Eastnine invites investors, analysts and media to a live presentation of the interim

Oxcia is focusing the development of OXC-101 on hematological cancers

Following a strategy and data review, Oxcia has chosen to re-prioritize the clinical development of OXC-101 from solid tumors to hematological cancers, specifically acute myeloid leukemia (AML). The preclinical program for OXC-101 has shown good results in both AML and other forms of hematological cancers, and data to date from the phase I/II study MAATEO confirm the previous results. Oxcia has initiated an expansion part of the MAATEO study in patients with refractory/relapsed AML (R/R AML), where OXC-101 is administered in combination with idarubicin (an anthracycline). - The first AML

Prisma Properties signs long lease agreement with Dollarstore in Växjö

On September the 27th, Prisma Properties (publ) signed a 10-year lease agreement with Dollarstore in Växjö, Sweden. The lease covers a store of 3,890 square meters, where Dollarstore will take over from the previous tenant, XXL.Dollarstore will relocate from its current store in Växjö to Prisma’s retail park in Samarkand. The new store is planned to open in March 2025. “Dollarstore has long been an important partner for us, and with this new store, we further strengthen our retail park with a strong discount tenant. The fact that Dollarstore is taking over the entire space immediately

SOFTSWISS Steps In to Assist Southern Poland After Severe Flooding

SOFTSWISS , a global tech supplier of software for the iGaming industry, along with its employees, has actively aided communities affected by the recent flooding in Southern Poland.In September, Storm Boris brought devastating floods to Central and Eastern Europe, causing widespread damage. Torrential rains left thousands of homes submerged, severely impacting numerous cities in Poland, the Czech Republic, and Romania. In Poland, the southern regions were hit the hardest, with dozens of towns requiring urgent evacuations and support for affected communities.

Helsinki Baltic Herring Market Kicks off Helsinki's Autumn Season

Baltic Herring market is held by the sea. Image source: City of Helsinki / City Environment Sector Helsinki Baltic Herring Market will be held at the Market Square on 6–12 October. The event honours Helsinki's autumn traditions and brings together fishers and many other vendors of artisanal products from around Finland. The Market offers visitors a chance to enjoy products from the Baltic Sea in a maritime market atmosphere. The Baltic herring jury will select the best Baltic herring products of the year on the opening day of the Market.  Helsinki Baltic Herring Market has

Neste strengthens chemical recycling logistics infrastructure in Europe in cooperation with Tepsa Netherlands

Neste Corporation, Press Release, 4 October 2024 at 1 p.m. (EET) Photo: Terminal of Tepsa Netherlands in Rotterdam. Source: Tepsa NetherlandsNeste enhances its chemical recycling capabilities by collaborating with Tepsa Netherlands on the storage and handling of liquefied waste plastic in Rotterdam, the Netherlands. This partnership, focused on the implementation of advanced aggregation tanks, underscores the company's commitment to expanding its liquefied waste plastic processing capabilities and advancing the circular economy. Following successful industrial-scale processing

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release 4 October 2024 at 12.45 p.m. (EEST) Sitowise Group Plc (the "Company") has on 3 October 2024 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley, according to which Morgan Stanley & Co International Plc's holding of the shares and votes of the Company increased to 11.15 percent on 2 October 2024. According to the notification, Morgan Stanley holds indirectly a total of 2,215,515 shares corresponding to 6.18 percent of the Company’s shares and votes, and a total of 1,779,

There are no items matching the current filter
There are no more items matching the current filter
Back to top